+- IOPList.Org (https://www.ioplist.org)
+-- Forum: Miscellaneous (https://www.ioplist.org/forumdisplay.php?fid=15)
+--- Forum: Medical Marijuana (https://www.ioplist.org/forumdisplay.php?fid=16)
+--- Thread: MM D9THC and Virus (/showthread.php?tid=5666)
MM D9THC and Virus - whatapain - 04-05-2020
No suprise I am a great fan of the benefits of MM
But find it important to share this here as a fyi during these times
https://www.researchgate.net/figure/Cannabinoids-and-Viral-Infections_tbl1_45200487
3. Conclusions
Cannabinoids are profoundly anti-inflammatory and impair many Ca2+-dependent enzyme systems
which are central to inflammatory and cell-autonomous antiviral responses. When viral-induced host
responses lead to immunopathology, as is seen in a rodent model of multiple sclerosis, TMEV-IDD, or
in a persistent infection of the central nervous system caused by a non-lytic virus, BDV, cannabinoid
treatment was beneficial.
In all other virus infections, both in vitro and in vivo, cannabinoid treatment led to disease
progression, increased pathology, and sometimes to host death. Therefore, in many clinical settings,
including latent infections caused by HIV-1 or HSV-1, and persistent infection of the liver caused by
HCV, cannabinoids lead to worsened disease outcome.
Acknowledgements
The generous support of the U.S. National Institutes of Health, both grants DC039746 and
NS039746, enabled my lab to perform these studies, and to summarize the work of many other labs.
Two former students, Ramon Antonio Herrera and Joseph H. Oved, contributed published [52] and
unpublished data, provided stimulating discussions and critically read this manuscript
RE: MM D9THC and Virus - magnet1153 - 04-05-2020
(04-05-2020, 01:09 AM)whatapain Wrote: No suprise I am a great fan of the benefits of MM
But find it important to share this here as a fyi during these times
https://www.researchgate.net/figure/Cannabinoids-and-Viral-Infections_tbl1_45200487
3. Conclusions
Cannabinoids are profoundly anti-inflammatory and impair many Ca2+-dependent enzyme systems
which are central to inflammatory and cell-autonomous antiviral responses. When viral-induced host
responses lead to immunopathology, as is seen in a rodent model of multiple sclerosis, TMEV-IDD, or
in a persistent infection of the central nervous system caused by a non-lytic virus, BDV, cannabinoid
treatment was beneficial.
In all other virus infections, both in vitro and in vivo, cannabinoid treatment led to disease
progression, increased pathology, and sometimes to host death. Therefore, in many clinical settings,
including latent infections caused by HIV-1 or HSV-1, and persistent infection of the liver caused by
HCV, cannabinoids lead to worsened disease outcome.
Acknowledgements
The generous support of the U.S. National Institutes of Health, both grants DC039746 and
NS039746, enabled my lab to perform these studies, and to summarize the work of many other labs.
Two former students, Ramon Antonio Herrera and Joseph H. Oved, contributed published [52] and
unpublished data, provided stimulating discussions and critically read this manuscript
I tried to go to the link, but I was taken to a site that denied access unless I create an account. Thanks for the info you presented in your post. I will continue to watch for updates.